ID   SYT2_RAT                Reviewed;         422 AA.
AC   P29101;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-1992, sequence version 1.
DT   24-JUL-2024, entry version 178.
DE   RecName: Full=Synaptotagmin-2 {ECO:0000305};
DE   AltName: Full=Synaptotagmin II {ECO:0000303|PubMed:1856191, ECO:0000312|RGD:3804};
DE            Short=SytII {ECO:0000303|PubMed:1856191};
GN   Name=Syt2 {ECO:0000312|RGD:3804};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=1856191; DOI=10.1016/s0021-9258(18)92733-x;
RA   Geppert M., Archer B.T. III, Suedhof T.C.;
RT   "Synaptotagmin II. A novel differentially distributed form of
RT   synaptotagmin.";
RL   J. Biol. Chem. 266:13548-13552(1991).
RN   [2]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH SYT1.
RX   PubMed=9867811; DOI=10.1074/jbc.274.1.59;
RA   Osborne S.L., Herreros J., Bastiaens P.I., Schiavo G.;
RT   "Calcium-dependent oligomerization of synaptotagmins I and II.
RT   Synaptotagmins I and II are localized on the same synaptic vesicle and
RT   heterodimerize in the presence of calcium.";
RL   J. Biol. Chem. 274:59-66(1999).
RN   [3]
RP   COFACTOR.
RX   PubMed=11823420; DOI=10.1093/emboj/21.3.270;
RA   Sugita S., Shin O.H., Han W., Lao Y., Suedhof T.C.;
RT   "Synaptotagmins form a hierarchy of exocytotic Ca(2+) sensors with distinct
RT   Ca(2+) affinities.";
RL   EMBO J. 21:270-280(2002).
RN   [4]
RP   FUNCTION AS C.BOTULINUM NEUROTOXIN TYPE G RECEPTOR (MICROBIAL INFECTION),
RP   AND SUBUNIT (MICROBIAL INFECTION).
RX   PubMed=15123599; DOI=10.1074/jbc.m403945200;
RA   Rummel A., Karnath T., Henke T., Bigalke H., Binz T.;
RT   "Synaptotagmins I and II act as nerve cell receptors for botulinum
RT   neurotoxin G.";
RL   J. Biol. Chem. 279:30865-30870(2004).
RN   [5]
RP   PHOSPHORYLATION AT THR-202 AND THR-386, AND MUTAGENESIS OF THR-202;
RP   ASP-231; ASP-310 AND THR-386.
RX   PubMed=15350218; DOI=10.1016/j.molcel.2004.07.018;
RA   Lee B.H., Min X., Heise C.J., Xu B.E., Chen S., Shu H., Luby-Phelps K.,
RA   Goldsmith E.J., Cobb M.H.;
RT   "WNK1 phosphorylates synaptotagmin 2 and modulates its membrane binding.";
RL   Mol. Cell 15:741-751(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-125 AND THR-128, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [7] {ECO:0007744|PDB:2NM1}
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 44-60 IN COMPLEX WITH C.BOTULINUM
RP   NEUROTOXIN TYPE B C-TERMINUS, FUNCTION AS C.BOTULINUM NEUROTOXIN TYPE B
RP   RECEPTOR (MICROBIAL INFECTION), SUBUNIT (MICROBIAL INFECTION), DOMAIN
RP   (MICROBIAL INFECTION), AND MUTAGENESIS OF MET-46; PHE-47; LEU-50; PHE-54;
RP   PHE-55; GLU-57 AND ASN-59.
RX   PubMed=17167421; DOI=10.1038/nature05387;
RA   Jin R., Rummel A., Binz T., Brunger A.T.;
RT   "Botulinum neurotoxin B recognizes its protein receptor with high affinity
RT   and specificity.";
RL   Nature 444:1092-1095(2006).
CC   -!- FUNCTION: Exhibits calcium-dependent phospholipid and inositol
CC       polyphosphate binding properties. May have a regulatory role in the
CC       membrane interactions during trafficking of synaptic vesicles at the
CC       active zone of the synapse. Plays a role in dendrite formation by
CC       melanocytes. {ECO:0000250|UniProtKB:P46097,
CC       ECO:0000250|UniProtKB:Q8N9I0}.
CC   -!- FUNCTION: (Microbial infection) Receptor for C.botulinum neurotoxin
CC       type B (BoNT/B, botB); unlike the case with BoNT/B interaction is not
CC       improved in the presence of gangliosides (PubMed:17167421). The toxin
CC       binds to the vesicular domain of Syt2 (residues 1-61)
CC       (PubMed:15123599). {ECO:0000269|PubMed:15123599}.
CC   -!- FUNCTION: (Microbial infection) Receptor for C.botulinum neurotoxin
CC       type G (BoNT/G, botG); unlike the case with BoNT/B interaction is not
CC       improved in the presence of gangliosides (PubMed:15123599). The toxin
CC       binds to the vesicular domain of Syt2 (residues 1-61)
CC       (PubMed:15123599). {ECO:0000269|PubMed:15123599}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00041,
CC         ECO:0000269|PubMed:11823420};
CC       Note=Binds 3 Ca(2+) ions per subunit. The ions are bound to the C2
CC       domains. {ECO:0000250|UniProtKB:P21707};
CC   -!- SUBUNIT: Homotetramer (Probable). Heterodimer; heterodimerizes with
CC       SYT1 in presence of calcium (PubMed:9867811). Interacts with SCAMP5 (By
CC       similarity). Interacts with STON2 (By similarity). Interacts with PRRT2
CC       (By similarity). {ECO:0000250|UniProtKB:P46097,
CC       ECO:0000250|UniProtKB:Q8N9I0, ECO:0000269|PubMed:9867811, ECO:0000305}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with C.botulinum neurotoxin
CC       type G (BoNT/G, botG). {ECO:0000269|PubMed:15123599}.
CC   -!- INTERACTION:
CC       P29101; Q9JIH7: Wnk1; NbExp=9; IntAct=EBI-458017, EBI-457953;
CC       P29101; A5JGM8: bont; Xeno; NbExp=2; IntAct=EBI-458017, EBI-16067725;
CC       P29101; P10844: botB; Xeno; NbExp=6; IntAct=EBI-458017, EBI-7661991;
CC       P29101; Q9H4A3: WNK1; Xeno; NbExp=2; IntAct=EBI-458017, EBI-457907;
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle, synaptic
CC       vesicle membrane {ECO:0000269|PubMed:9867811}; Single-pass membrane
CC       protein {ECO:0000255}. Cytoplasmic vesicle, secretory vesicle,
CC       chromaffin granule membrane {ECO:0000250|UniProtKB:P21707}; Single-pass
CC       membrane protein. Cytoplasm.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in brain regions such as
CC       the spinal cord, brain stem and cerebellum (PubMed:1856191).
CC       {ECO:0000269|PubMed:1856191}.
CC   -!- DOMAIN: The first C2 domain mediates Ca(2+)-dependent phospholipid
CC       binding. {ECO:0000250|UniProtKB:P46097}.
CC   -!- DOMAIN: The second C2 domain mediates interaction with Stonin 2. The
CC       second C2 domain mediates phospholipid and inositol polyphosphate
CC       binding in a calcium-independent manner.
CC       {ECO:0000250|UniProtKB:P46097}.
CC   -!- DOMAIN: (Microbial infection) Binding to BoNT/B induces formation of an
CC       alpha-helix in the membrane-proximal extracytoplasmic domain
CC       (PubMed:17167421). {ECO:0000305|PubMed:17167421}.
CC   -!- PTM: Phosphorylation at Thr-202 by WNK1, changes the calcium
CC       requirement for SYT2-binding to phospholipid membranes.
CC       {ECO:0000269|PubMed:15350218}.
CC   -!- SIMILARITY: Belongs to the synaptotagmin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M64488; AAA63502.1; -; mRNA.
DR   PIR; A39454; BMRT2Y.
DR   RefSeq; NP_036797.1; NM_012665.1.
DR   PDB; 2NM1; X-ray; 2.15 A; B=44-60.
DR   PDB; 4ISR; X-ray; 2.59 A; D/E/F=40-60.
DR   PDBsum; 2NM1; -.
DR   PDBsum; 4ISR; -.
DR   AlphaFoldDB; P29101; -.
DR   SMR; P29101; -.
DR   BioGRID; 246928; 4.
DR   CORUM; P29101; -.
DR   DIP; DIP-32642N; -.
DR   IntAct; P29101; 8.
DR   MINT; P29101; -.
DR   STRING; 10116.ENSRNOP00000006637; -.
DR   GlyCosmos; P29101; 1 site, No reported glycans.
DR   GlyGen; P29101; 1 site.
DR   iPTMnet; P29101; -.
DR   PhosphoSitePlus; P29101; -.
DR   SwissPalm; P29101; -.
DR   PaxDb; 10116-ENSRNOP00000006637; -.
DR   Ensembl; ENSRNOT00055036921; ENSRNOP00055030009; ENSRNOG00055021595.
DR   Ensembl; ENSRNOT00060025448; ENSRNOP00060020286; ENSRNOG00060014883.
DR   Ensembl; ENSRNOT00065035765; ENSRNOP00065028826; ENSRNOG00065021046.
DR   GeneID; 24805; -.
DR   KEGG; rno:24805; -.
DR   UCSC; RGD:3804; rat.
DR   AGR; RGD:3804; -.
DR   CTD; 127833; -.
DR   RGD; 3804; Syt2.
DR   eggNOG; KOG1028; Eukaryota.
DR   InParanoid; P29101; -.
DR   OrthoDB; 590187at2759; -.
DR   PhylomeDB; P29101; -.
DR   Reactome; R-RNO-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-RNO-8856828; Clathrin-mediated endocytosis.
DR   PRO; PR:P29101; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; ISO:RGD.
DR   GO; GO:0042584; C:chromaffin granule membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0031045; C:dense core granule; IBA:GO_Central.
DR   GO; GO:0070382; C:exocytic vesicle; IBA:GO_Central.
DR   GO; GO:0031594; C:neuromuscular junction; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0030672; C:synaptic vesicle membrane; IDA:SynGO.
DR   GO; GO:0043195; C:terminal bouton; HDA:ParkinsonsUK-UCL.
DR   GO; GO:0005509; F:calcium ion binding; ISO:RGD.
DR   GO; GO:0005544; F:calcium-dependent phospholipid binding; IDA:BHF-UCL.
DR   GO; GO:0030276; F:clathrin binding; IBA:GO_Central.
DR   GO; GO:0043533; F:inositol 1,3,4,5 tetrakisphosphate binding; ISS:UniProtKB.
DR   GO; GO:0001786; F:phosphatidylserine binding; ISO:RGD.
DR   GO; GO:0000149; F:SNARE binding; IBA:GO_Central.
DR   GO; GO:0019905; F:syntaxin binding; IDA:BHF-UCL.
DR   GO; GO:0048791; P:calcium ion-regulated exocytosis of neurotransmitter; IBA:GO_Central.
DR   GO; GO:0099502; P:calcium-dependent activation of synaptic vesicle fusion; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:1903861; P:positive regulation of dendrite extension; ISO:RGD.
DR   GO; GO:0048488; P:synaptic vesicle endocytosis; IBA:GO_Central.
DR   GO; GO:0016079; P:synaptic vesicle exocytosis; TAS:RGD.
DR   CDD; cd08385; C2A_Synaptotagmin-1-5-6-9-10; 1.
DR   CDD; cd08402; C2B_Synaptotagmin-1; 1.
DR   CDD; cd21964; Syt2_N; 1.
DR   Gene3D; 2.60.40.150; C2 domain; 2.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR001565; Synaptotagmin.
DR   PANTHER; PTHR10024; SYNAPTOTAGMIN; 1.
DR   PANTHER; PTHR10024:SF223; SYNAPTOTAGMIN-2; 1.
DR   Pfam; PF00168; C2; 2.
DR   PRINTS; PR00360; C2DOMAIN.
DR   PRINTS; PR00399; SYNAPTOTAGMN.
DR   SMART; SM00239; C2; 2.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 2.
DR   PROSITE; PS50004; C2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Cytoplasm; Cytoplasmic vesicle; Differentiation;
KW   Glycoprotein; Membrane; Metal-binding; Phosphoprotein; Reference proteome;
KW   Repeat; Synapse; Transmembrane; Transmembrane helix.
FT   CHAIN           1..422
FT                   /note="Synaptotagmin-2"
FT                   /id="PRO_0000183944"
FT   TOPO_DOM        1..60
FT                   /note="Vesicular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        61..87
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        88..422
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          142..261
FT                   /note="C2 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          273..406
FT                   /note="C2 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   REGION          16..43
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          102..141
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          136..382
FT                   /note="Phospholipid binding"
FT                   /evidence="ECO:0000305"
FT   COMPBIAS        103..122
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        123..137
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         172
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         173
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         173
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         179
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         231
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         231
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         232
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         233
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         233
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         233
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         236
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         237
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         239
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         239
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         304
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         310
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         364
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         366
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   MOD_RES         125
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         128
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         202
FT                   /note="Phosphothreonine; by WNK1"
FT                   /evidence="ECO:0000269|PubMed:15350218"
FT   MOD_RES         230
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P46097"
FT   MOD_RES         386
FT                   /note="Phosphothreonine; by WNK1"
FT                   /evidence="ECO:0000269|PubMed:15350218"
FT   CARBOHYD        32
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   MUTAGEN         46
FT                   /note="M->A: Nearly wild-type binding of fragment 1-61 to
FT                   BoNT/B heavy chain."
FT                   /evidence="ECO:0000269|PubMed:17167421"
FT   MUTAGEN         47
FT                   /note="F->A: No binding of fragment 1-61 to BoNT/B heavy
FT                   chain."
FT                   /evidence="ECO:0000269|PubMed:17167421"
FT   MUTAGEN         50
FT                   /note="L->A: Decreased binding of fragment 1-61 to BoNT/B
FT                   heavy chain."
FT                   /evidence="ECO:0000269|PubMed:17167421"
FT   MUTAGEN         54
FT                   /note="F->A: No binding of fragment 1-61 to BoNT/B heavy
FT                   chain."
FT                   /evidence="ECO:0000269|PubMed:17167421"
FT   MUTAGEN         55
FT                   /note="F->A: No binding of fragment 1-61 to BoNT/B heavy
FT                   chain."
FT                   /evidence="ECO:0000269|PubMed:17167421"
FT   MUTAGEN         57
FT                   /note="E->K: No binding of fragment 1-61 to BoNT/B heavy
FT                   chain."
FT                   /evidence="ECO:0000269|PubMed:17167421"
FT   MUTAGEN         59
FT                   /note="N->H: Nearly wild-type binding of fragment 1-61 to
FT                   BoNT/B heavy chain."
FT                   /evidence="ECO:0000269|PubMed:17167421"
FT   MUTAGEN         202
FT                   /note="T->A: Decreased phosphorylation by WNK1."
FT                   /evidence="ECO:0000269|PubMed:15350218"
FT   MUTAGEN         231
FT                   /note="D->S: Impaired calcium-binding and phosphorylation
FT                   by WNK1."
FT                   /evidence="ECO:0000269|PubMed:15350218"
FT   MUTAGEN         310
FT                   /note="D->N: Impaired calcium-binding and phosphorylation
FT                   by WNK1."
FT                   /evidence="ECO:0000269|PubMed:15350218"
FT   MUTAGEN         386
FT                   /note="T->A: Decreased phosphorylation by WNK1."
FT                   /evidence="ECO:0000269|PubMed:15350218"
FT   HELIX           47..59
FT                   /evidence="ECO:0007829|PDB:2NM1"
SQ   SEQUENCE   422 AA;  47210 MW;  D852AF5387E0C7FD CRC64;
     MRNIFKRNQE PIVAPATTTA TMPLAPAAPA DNSTESTGTG ESQEDMFAKL KDKFFNEINK
     IPLPPWALIA MAVVAGLLLL TCCFCICKKC CCKKKKNKKE KGKGMKNAMN MKDMKGGQDD
     DDAETGLTEG EGEGEEEKEP ENLGKLQFSL DYDFQANQLT VGVLQAAELP ALDMGGTSDP
     YVKVFLLPDK KKKYETKVHR KTLNPAFNET FTFKVPYQEL GGKTLVMAIY DFDRFSKHDI
     IGEVKVPMNT VDLGQPIEEW RDLQGGEKEE PEKLGDICTS LRYVPTAGKL TVCILEAKNL
     KKMDVGGLSD PYVKIHLMQN GKRLKKKKTT VKKKTLNPYF NESFSFEIPF EQIQKVQVVV
     TVLDYDKLGK NEAIGKIFVG SNATGTELRH WSDMLANPRR PIAQWHSLKP EEEVDALLGK
     NK
//
